CTIX up 180% in the last 6 months including this recent pullback -
I'm betting that the next 6 months see an even larger % increase. I have never been in a stock before that has CTIX's potential.
The Prurisol trial is right around the corner.
The news at this stage of the Kevetrin trial is as good as we could hope for -
Dr. Krishna Menon, Chief Scientific Officer at Cellceutix, commented, “We are still at the early stages of the clinical trial. To date, we have not observed any dose limiting toxicities. Initial pharmacokinetic (PK) data from the clinical trial has been received and is consistent with the animal data, which is a very optimistic sign moving forward. Additional information on these PK studies will be forthcoming at ASCO. We are now looking forward to receiving data from the p21 biomarker studies which is expected in March 2013.”